Drug Shortage Report for ACT CLARITHROMYCIN XL

Last updated on 2020-05-29 History
Report ID 102945
Drug Identification Number 02403196
Brand name ACT CLARITHROMYCIN XL
Common or Proper name CLARITHROMYCIN FC TABLETS 500MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN
Strength(s) 500MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 60
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2020-05-15
Estimated end date 2020-06-30
Actual end date 2020-05-27
Shortage status Resolved
Updated date 2020-05-29
Company comments Allocating to 100% of our market.
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-05-29 French Compare
v12 2020-05-29 English Compare
v11 2020-05-21 French Compare
v10 2020-05-21 English Compare
v9 2020-05-16 English Compare
v8 2020-05-08 French Compare
v7 2020-05-08 English Compare
v6 2020-04-23 French Compare
v5 2020-04-23 English Compare
v4 2020-02-13 French Compare
v3 2020-02-13 English Compare
v2 2020-01-09 French Compare
v1 2020-01-09 English Compare

Showing 1 to 13 of 13